Analysis of HLA class I and II alleles in sporadic inclusion-body myositis

Journal of Neurology

Volumn 250, Issue 11, 2003, Pages 1313-1317

  Lampe, Johannes B ^a,e   Gossrau, Gudrun ^a,b   Kempe, Andrea ^a   Füssel, Monika ^a   Schwurack, Katja ^a   Schröder, Rolf ^b   Krause, Sabine ^c   Kohnen, Ralf ^d   Walter, Maggie C ^c   Reichmann, Heinz ^a   Lochmüller, Hanns ^c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d IMEREM GmbH   (Germany)

^e BAYER PHARMA AG   (Germany)

Author keywords

Alzheimer; Autoimmune; HLA; Inclusion body; Myositis; Prion

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ALLELE; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; HLA SYSTEM; HLA TYPING; HUMAN; INCLUSION BODY MYOSITIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS;

ALLELES; GENE FREQUENCY; GENES, MHC CLASS I; GENES, MHC CLASS II; HUMANS; LINKAGE DISEQUILIBRIUM; MYOSITIS, INCLUSION BODY; POLYMERASE CHAIN REACTION;

EID: 10744233697     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-003-0204-3     Document Type: Article

References (38)

1. Abarbanel JM, Lichtenfeld Y, Zirkin H, Louzon Z, Osimani A, Farkash P, Herishanu Y (1988) Inclusion body myositis in post-poliomyelitis muscular atrophy. Acta Neurol Scand 78:81-84
2. Askanas V, Engel WK (1995) New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies. Curr Opin Rheumatol 7:486-496
3. Askanas V, Bilak M, Engel WK, Alvarez RB, Tome F, Leclerc A (1993) Prion protein is abnormally accumulated in inclusion-body myositis. Neuroreport 5:25-28
4. Askanas V, Engel WK, Yang CC, Alvarez RB, Lee VM, Wisniewski T (1998) Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy. Am J Pathol 152:889-895
5. Banwell BL, Engel AG (2000) AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 54:1033-1041
6. Bender A, Behrens L, Engel AG, Hohlfeld R (1998) T-cell heterogeneity in muscle lesions of inclusion body myositis. J Neuroimmunol 84:86-91
7. Carroll MC, Katzman P, Alicot EM, Koller BH, Geraghty DE, Orr HT, Strominger JL, Spies T (1987) Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci USA 84:8535-8539
8. Cascino I, D'Alfonso S, Cappello N, Giordano M, Pugliese A, Awdeh Z, Alper CA, Richiardi PM (1993) Gametic association of HSP70-1 promoter region alleles and their inclusion in extended HLA haplotypes. Tissue Antigens 42:62-66
9. Chou SM (1985) Inclusion body myositis. A possible chronic persistent muscle infection by mumps virus. Cleve Clin Q 52:583-589
10. Chou SM (1993) Inclusion body myositis. Baillieres Clin Neurol 2:557-577
11. Cupler EJ, Leon-Monzon M, Miller J, Semino-Mora C, Anderson TL, Dalakas MC (1996) Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain 119 (Pt 6):1887-1893
12. Dalakas MC (1995) Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease. J Clin Immunol 15:70S-75S
13. Dalakas MC, Sonies BC, Lopez-Devine J, Sapper DJ (1996) Dysphagia as a frequent manifestation in patients with inclusion body myositis. Neurology 46 (Suppl.):A116
14. Dalakas MC, Koffman B, Fujii M, Spector S, Sivakumar K, Cupler E (2001) A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM. Neurology 56:323-327
15. Dausset J, Legrand L, Lepage V, Contu L, Marcelli-Barge A, Wildloecher I, Benajam A, Meo T, Degos L (1978) A haplotype study of HLA complex with special reference to the HLA-DR series and to Bf. C2 and glyoxalase I polymorphisms. Tissue Antigens 12: 297-307
16. Dunham I, Sargent CA, Trowsdale J, Campbell RD (1987) Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. Proc Natl Acad Sci USA 84:7237-7241
17. Eichler H, Richter E, Schwartz K, Woelpel A, Goldmann SF (1997) "Caucasian German Normal" in HLA 1998 DW Gjestson, Terasaki PI, eds), Larosa, Kansas, USA, American Society for Histocompatibility and Immunogenetics, pp 150-151
18. Fyhr IM, Moslemi AR, Mosavi AA, Lindberg C, Tarkowski A, Oldfors A (1997) Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis. J Neuroimmunol 79: 185-189
19. Garlepp MJ (1993) Immunogenetics of inflammatory myopathies. Baillieres Clin Neurol 2:579-597
20. Garlepp MJ, Laing B, Zilko PJ, Ollier W, Mastaglia FL (1994) HLA associations with inclusion body myositis. Clin Exp Immunol 98:40-45
21. Hohlfeld R, Engel AG (1991) Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies. Ann Neurol 29: 498-507
22. Hohlfeld R, Goebels N, Engel AG (1993) Cellular mechanisms in inflammatory myopathies. Baillieres Clin Neurol 2:617-635
23. Koffman BM, Rugiero M, Dalakas MC (1998) Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve 21:115-117
24. Koffman BM, Sivakumar K, Simonis T, Stroncek D, Dalakas MC (1998) HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. J Neuroimmunol 84:139-142
25. Kok CC, Croager EJ, Witt CS, Kiers L, Mastaglia FL, Abraham LJ, Garlepp MJ (1999) Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex. Immunogenetics 49:508-516
26. Lindberg C, Oldfors A, Tarkowski A (1994) Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies. Eur J Immunol 24:2659-2663
27. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ (1989) Inclusion body myositis. Observations in 40 patients. Brain 112 (Pt 3):727-747
28. Mikol J, Engel AG (1994) Inclusion body myositis. In: Myology AG Engel, Franzini-Armstrong C, eds), New York, McGraw-Hill, pp 1384-1398
29. Mueller CR, Goldmann SF, Wegener S (1997) "German Normal" in HLA 1998 DW Gjestson, Terasaki PI (eds) Larosa, Kansas, USA, American Society for Histocompatibility and Immunogenetics 1997, pp 154-157
30. Mueller CR, Ehninger G, Goldmann SF (2003) Gene and haplotype frequencies for the loci HLA-A, HLA-B, and HLA-DR based on over 13,000 German blood donors. Hum Immunol 64:137-151
31. Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E, Danning C, Wada R, Thompson C, Bahtiyar G, Craft J, Hooft Van Huijsduijnen R, Plotz P (2000) Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA 97: 9209-9214
32. Rider LG, Gurley RC, Pandey JP, Garcia de la Torre I, Kalovidouris AE, O'Hanlon TP, Love LA, Hennekam RC, Baumbach LL, Neville HE, Garcia CA, Klingman J, Gibbs M, Weisman MH, Targoff IN, Miller FW (1998) Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum 41:710-719
33. Sargent CA, Dunham I, Trowsdale J, Campbell RD (1989) Human major histocompatibility complex contains genes for the major heat shock protein HSP70. Proc Natl Acad Sci USA 86: 1968-1972
34. Schlesinger I, Soffer D, Lossos A, Meiner Z, Argov Z (1996) Inclusion body myositis: atypical clinical presentations. Eur Neurol 36:89-93
35. Sekul EA, Dalakas MC (1993) Inclusion body myositis: new concepts. Semin Neurol 13:256-263
36. Terwilliger J, Ott J (1994) Handbook for Human Genetic Linkage. Johns Hopkins University Press, Baltimore
37. Vershuuren JJ, van Engelen BGM, van der Hoeven H, Hoogendijk J (1997) Diagnostic criteria of inclusion body myositis. A Emery (ed), London, Royal Society of Medicine Press, pp 81-85
38. Walter MC, Lochmuller H, Toepfer M, Schlotter B, Reilich P, Schroder M, Muller-Felber W, Pongratz D (2000) High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study. J Neurol 247:22-28